Skip to main content

Case Presentation: Sperm Banking in Patient Diagnosed with Acute Myeloid Leukemia

  • Chapter
  • First Online:
Textbook of Oncofertility Research and Practice

Abstract

A 23-year-old man presented to a referring hospital emergency room with gradually worsening throat pain. He was febrile to 38.4°C and his exam was notable for very large, erythematous tonsils. His labs were notable for a white blood cell (WBC) count of 119.8 K/cu mm (3.50–10.80 K/cu mm) with 91% blasts, creatinine elevated to 1.63 mg/dL (0.70–1.30 mg/dL), and lactate dehydrogenase (LDH) of 1122 U/L (≤250 U/L). Computed tomography (CT) of the neck was remarkable for the enlargement of tonsils and lymph nodes with a narrowing of the nasopharyngeal airway. He was started empirically on cefepime and transferred to a tertiary care intensive care unit (ICU) due to concern for impending airway compromise in the setting of likely new acute leukemia. Upon arrival, his peripheral blood smear was notable for numerous circulating blasts with a high nuclear to cytoplasmic ratio, a moderate amount of basophilic cytoplasm, open chromatin, and prominent nucleoli suggestive of monoblastic differentiation. Flow cytometry confirmed an immunophenotype consistent with acute myeloid leukemia (AML).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209–21.

    Article  CAS  Google Scholar 

  2. Schuurhuis GJ, Heuser M, Freeman S, et al. Minimal/measureable residual disease in AML: consensus document from ELN MRD Working Party. Blood. 2018;131:1275–91. Epub ahead of print.

    Article  CAS  Google Scholar 

  3. Doehner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–52.

    Article  CAS  Google Scholar 

  4. Nass SJ, Beaupin LK, Demark-Wahnefried W, et al. Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist. 2015;20(2):186–95.

    Article  Google Scholar 

  5. Rechis R, Bann C, Arvery S, et al. Unique risks & vulnerabilities of AYA patients across the lifespan, LIVESTRONG Foundation: AYA survey results. Presented at Institute of Medicine National Cancer Policy Forum/LIVESTRONG Workshop on Addressing the Needs of Adolescents and Young Adults with Cancer, Washington, DC; 2013.

    Google Scholar 

  6. Sekeres MA, Elson P, Kalaycio ME, et al. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood. 2009;113(1):28–36.

    Article  CAS  Google Scholar 

  7. Massarotti C, Scaruffi P, Lambertini M, et al. State of the art on oocyte cryopreservation in female cancer patients: a critical review of the literature. Cancer Treat Rev. 2017;57:50–7.

    Article  Google Scholar 

  8. Johnson MD, Cooper AR, Jungheim ES, et al. Sperm banking for fertility preservation: a 20-year experience. Eur J Obstet Gynecol Reprod Biol. 2013;170:177–82.

    Article  Google Scholar 

  9. Chung K, Irani J, Knee G, et al. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol. 2004;113S:S7–S11.

    Article  Google Scholar 

  10. Auger J, Sermondade N, Eustache F. Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations. Basic Clinical Androl. 2016;26(3):1–10.

    Google Scholar 

  11. Burns KC, Hoefgen H, Strine A, Dasgupta R. Fertility preservation options in pediatric and adolescent patients with cancer. Cancer. 2018;124(9):1867–76. https://doi.org/10.1002/cncr.31255. Epub 2018 Jan 25.

  12. Banerjee R, Tsiapali E. Occurrence and recall rates of fertility discussions with young breast cancer patients. Support Care Cancer. 2016;24:163–71.

    Article  Google Scholar 

  13. Deruyver Y, Vanderschueren D, Van der Aa F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology. 2014;2:20–4.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brandon Hayes-Lattin .

Editor information

Editors and Affiliations

Review Questions and Answers

Review Questions and Answers

  1. Q1.

    What is NOT a barrier to preserving fertility for those with cancer requiring chemotherapy?

    1. (a)

      Providers taking the time during a busy period to go over the risks to fertility

    2. (b)

      Cost of fertility-preserving measures

    3. (c)

      Medical status of the patient

    4. (d)

      Importance of fertility preservation to patients

    5. (e)

      Available facilities for fertility preservation

  1. A1.

    (d)

  2. Q2.

    True or false? There have been reports of transferring leukemia through egg or sperm preservation.

  3. A2.

    False

  1. Q3.

    What percentage of patients remembers discussing the impact of fertility of therapy with his/her provider?

    1. (a)

      10%

    2. (b)

      25%

    3. (c)

      50%

    4. (d)

      65%

    5. (e)

      90%

  1. A3.

    (c)

  1. Q4.

    What is the best option for a male patient who has reached sexual maturity but is unable to provide semen and still wishes to preserve fertility?

    1. (a)

      Nothing

    2. (b)

      TESE

    3. (c)

      Sexual education

    4. (d)

      Only offering fertility treatment following therapy

  1. A4.

    (b)

  2. Q5.

    True or false? Men with leukemia have decreased sperm counts in comparison to their healthy peers and to those of similar age with chronic diseases making sperm backing successfully more challenging.

  3. A5.

    True

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

DuVall, A.S., Hedges, J.C., Hayes-Lattin, B. (2019). Case Presentation: Sperm Banking in Patient Diagnosed with Acute Myeloid Leukemia. In: Woodruff, T., Shah, D., Vitek, W. (eds) Textbook of Oncofertility Research and Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-02868-8_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02868-8_51

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02867-1

  • Online ISBN: 978-3-030-02868-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics